glaucoma
News/ News/ Sales and Marketing
Oculis SA and EBAC join to drive ophthalmology innovation
Nicole Raleigh
biopharma, business, EBAC, eye disease, eye drops, glaucoma, Oculis, ophthalmology, research and development, topical treatment
0 Comment
News/ News/ Sales and Marketing
Alcon eyes $770m takeover of ophthalmology specialist Aerie
Phil Taylor
aerie pharmaceuticals, Alcon, glaucoma, M&A, ophthalmology
0 Comment
New Horizon for Treatment of Inherited Retinal Dystrophy
Pavan Solanki
glaucoma, Oncology, pharma, retinal dystrophy, voretigene
0 Comment
Latest developments and innovations in ocular gene edit
Partner content/ Partner Content/ Press releases
Queen’s University Belfast and Santen to Present Opening Keynote this November
Pavan Solanki
gene editing, gene therapy, glaucoma, ophthalmology, santen
0 Comment
Ophthalmic Drugs Conference London
Astellas buys eye gene therapy biotech Quethera for $109m
Piotr Wnuk
Astellas, gene therapy, glaucoma, ocular disorders, ophthalmology, Quethera
0 Comment
Ophthalmic Drugs 2018
Pavan Solanki
glaucoma, NHS, ophthalmic, ophthalmology, retina
0 Comment
Ophthalmic Drugs Conference 2018
Healthcare/ Partner content/ Press releases
SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks away!
Pavan Solanki
glaucoma, lentivector, ophthalmic, preclinical, vision
0 Comment
Europe’s Leading Ophthalmic Conference
Healthcare/ Partner content/ Press releases
Spotlight on Key Sessions at Ophthalmic Drugs this November
Pavan Solanki
drugs, glaucoma, ophthalmic, ophthalmology, technologies
Sessions at Ophthalmic Drugs